Highlights and Quick Summary
- Net Debt/EBITDA for the quarter ending June 30, 2022 was 0.74 (a -67.96% decrease compared to previous quarter)
- Year-over-year quarterly Net Debt/EBITDA decreased by -76.25%
- Annual Net Debt/EBITDA for 2022 was 0.2 (a -86.57% decrease from previous year)
- Annual Net Debt/EBITDA for 2021 was 1.48 (a -0.3% decrease from previous year)
- Annual Net Debt/EBITDA for 2021 was 1.48 (a 25.29% increase from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.
Historical Net Debt/EBITDA of Benitec Biopharma LimitedMost recent Net Debt/EBITDAof BNTC including historical data for past 10 years.
Interactive Chart of Net Debt/EBITDA of Benitec Biopharma Limited
Benitec Biopharma Limited Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)
Business Profile of Benitec Biopharma Limited